GE Healthcare Posts 1% Annual Revenue Growth in 2024 Financials
Company

GE Healthcare Posts 1% Annual Revenue Growth in 2024 Financials

Betta Pharma Files for EMA Approval of ALK Inhibitor Ensartinib
CompanyDrug

Betta Pharma Files for EMA Approval of ALK Inhibitor Ensartinib

Lee Kai and Yangshun Partner on Polyvinyl Alcohol Embolization Microspheres
CompanyDeals

Lee Kai and Yangshun Partner on Polyvinyl Alcohol Embolization Microspheres

Nanos Medical Raises Over RMB300m to Boost Otolaryngology Device Lead
CompanyDeals

Nanos Medical Raises Over RMB300m to Boost Otolaryngology Device Lead

SciClone's Vibativ Approved by NMPA for HABP/VABP Treatment
CompanyDrug

SciClone’s Vibativ Approved by NMPA for HABP/VABP Treatment

Trinomab's Antitetanus mAb Injection TNM002 Approved by NMPA
CompanyDeals

Trinomab’s Antitetanus mAb Injection TNM002 Approved by NMPA

NMPA Releases 90th Batch of Reference Drugs for GQCE
Policy / Regulatory

NMPA Releases 90th Batch of Reference Drugs for GQCE

Accropeutics Doses First Patient in AC-101 Phase Ib UC Study
CompanyDrug

Accropeutics Doses First Patient in AC-101 Phase Ib UC Study

China Launches Major Public Health Initiatives to Enhance Healthcare Accessibility
Policy / Regulatory

China Launches Major Public Health Initiatives to Enhance Healthcare Accessibility

Sanofi and J&J's E. coli Vaccine Fails Phase III Study
CompanyDrug

Sanofi and J&J’s E. coli Vaccine Fails Phase III Study

Antengene's Xpovio Included in Taiwan's NHI Drug List for Myeloma Treatment
CompanyDrug

Antengene’s Xpovio Included in Taiwan’s NHI Drug List for Myeloma Treatment

Boehringer Ingelheim Partners with ExpressionEdits on Gene Therapy Tech
CompanyDeals

Boehringer Ingelheim Partners with ExpressionEdits on Gene Therapy Tech